冠心病患者血清高敏C反应蛋白和Periostin蛋白与冠状动脉病变严重程度的相关性

被引：46

作者：

凌琳 ^{[1
]}

承艳 ^{[2
]}

康丽娜 ^{[1
]}

徐标 ^{[1
]}

机构：

[1] 南京大学医学院附属鼓楼医院心内科

[2] 南京大学医学院

来源：

中国动脉硬化杂志 | 2013年 / 05期

关键词：

冠心病; 高敏C反应蛋白; Periostin蛋白; 冠状动脉狭窄;

D O I：

暂无

中图分类号：

R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）];

学科分类号：

100201 [内科学];

摘要：

目的测定冠心病患者血清高敏C反应蛋白与Periostin蛋白水平,研究其与冠状动脉狭窄程度的相关性。方法采用酶联免疫吸附法测定87例冠心病患者血清高敏C反应蛋白和Periostin蛋白水平,其中急性心肌梗死57例,不稳定型心绞痛30例,分析两组间高敏C反应蛋白和Periostin蛋白表达的相关性。根据造影结果对冠状动脉狭窄程度进行Gensini评分,分析高敏C反应蛋白和Periostin蛋白水平与冠状动脉狭窄严重程度的关系。结果急性心肌梗死患者血清高敏C反应蛋白和Periostin蛋白水平显著高于不稳定型心绞痛患者(P<0.05或P<0.001)。高敏C反应蛋白(r=0.232,P<0.05)和Periostin蛋白水平(r=0.624,P<0.001)随冠状动脉Gensini评分增高而升高,呈正相关。血清高敏C反应蛋白与Periostin蛋白水平呈正相关(r=0.223,P<0.05)。结论血清高敏C反应蛋白和Periostin蛋白水平在冠心病急性心肌梗死患者较不稳定型心绞痛患者中显著增高,其水平与冠状动脉狭窄程度呈正相关,能较好的反映疾病的严重程度,预测病情。

引用

页码：440 / 444

页数：5

共 10 条

[1]

冠心病患者血浆periostin蛋白与血管内皮生长因子的相关性 [J].

杨汆 ;

丁志坚 ;

朱傲霜 ;

刘小宇 ;

马玲娣 ;

王芳芳 .

中国动脉硬化杂志, 2011, (02) :135-138

[2]

冠心病患者载脂蛋白A5基因多态性与冠状动脉病变程度的相关性 [J].

邱方 ;

张葵 ;

徐标 ;

顾光煜 ;

李雷 .

中国动脉硬化杂志, 2007, (09) :695-698

[3]

Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association[J] Véronique L. Roger;Alan S. Go;Donald M. Lloyd-Jones;Emelia J. Benjamin;Jarett D. Berry;William B. Borden;Dawn M. Bravata;Shifan Dai;Earl S. Ford;Caroline S. Fox;Heather J. Fullerton;Cathleen Gillespie;Susan M. Hailpern;John A. Heit;Virginia J. Howard;Brett M. Kissela;Steven J. Kittner;Daniel T. Lackland;Judith H. Lichtman;Lynda D. Lisabeth;Diane M. Makuc;Gregory M. Marcus;Ariane Marelli;David B. Matc

[4]

Periostin Is a Novel Factor in Cardiac Remodeling After Experimental and Clinical Unloading of the Failing Heart[J] William E. Stansfield;Nancy M. Andersen;Ru-Hang Tang;Craig H. Selzman The Annals of Thoracic Surgery 2009,

[5]

Utility of C-Reactive Protein for Cardiovascular Risk Stratification Across Three Age Groups in Subjects Without Existing Cardiovascular Diseases[J] Mark Hamer;Yoichi Chida;Emmanuel Stamatakis The American Journal of Cardiology 2009,

[6]

Genetic Manipulation of Periostin Expression Reveals a Role in Cardiac Hypertrophy and Ventricular Remodeling[J] Toru Oka;Jian Xu;Robert A. Kaiser;Jaime Melendez;Michael Hambleton;Michelle A. Sargent;Angela Lorts;Eric W. Brunskill;Gerald W. Dorn;Simon J. Conway;Bruce J. Aronow;Jeffrey Robbins;Jeffery D. Molkentin Circulation Research 2007,

[7]

Future of Biomarkers in Acute Coronary Syndromes Moving Toward a Multimarker Strategy[J] David A Morrow;Eugene Braunwald Circulation 2003,

[8]

C-Reactive Protein; a Sensitive Marker of Inflammation; Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men: Results From the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study; 1984 to 1992[J] Wolfgang Koenig;Malte Sund;Margit Frohlich;Hans-Gunther Fischer;Hannelore Lowel;Angela Doring;Winston L. Hutchinson;Mark B. Pepys Circulation 1999,

[9]

Comparison of Apolipoprotein and Proteoglycan Deposits in Human Coronary Atherosclerotic Plaques: Colocalization of Biglycan With Apolipoproteins[J] Kevin D. O'Brien;Katherine L. Olin;Charles E. Alpers;Winnie Chiu;Marina Ferguson;Kelly Hudkins;Thomas N. Wight;Alan Chait Circulation 1998,

[10]

Survival After the Onset of Congestive Heart Failure in Framingham Heart Study Subjects[J] Kalon K.L. HO;Keaven M. Anderson;William B. Kannel;William Grossman;Daniel Levy Circulation 1993,

← 1 →